Literature DB >> 23239119

Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey.

Kunihiro Yamagata1, Joichi Usui2, Hitoshi Sugiyama3, Kosaku Nitta4, Takashi Wada5, Eri Muso6, Yoshihiro Arimura7, Akio Koyama8, Hirofumi Makino3, Seiichi Matsuo9.   

Abstract

Renal involvement with significant organ damage is common in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). As a result, it is independently referred to ANCA-associated renal vasculitis. Clinically, ANCA-associated renal vasculitis is characterized by rapidly progressive glomerulonephritis. Pathologically, it is defined by pauci-immune type necrotizing and crescentic glomerulonephritis. According to previous reports from all over the world, the etiology, prevalence, and prognosis of RPGN including ANCA-associated renal vasculitis varies among races and periods. To elucidate the clinical characteristics of Japanese RPGN patients, a registry derived from a questionnaire survey was established in 1999 and maintained until 2006. As a result, 1,772 cases were collected, analyzed, and reported previously. In this mini-review, we outline the characteristic clinical findings of Japanese patients (Asian) with ANCA-associated renal vasculitis, based on the registry data.

Entities:  

Mesh:

Year:  2012        PMID: 23239119     DOI: 10.1007/s10157-012-0740-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  4 in total

1.  A new vasculitis activity score for predicting death in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis patients.

Authors:  Kiyomi Koike; Kei Fukami; Koji Yonemoto; Ryuji Iwatani; Rimi Obata; Kaoru Ueda; Maki Toyonaga; Seiji Ueda; Atsuko Ohara; Kazuhito Takeda; Sho-Ichi Yamagishi; Seiya Okuda
Journal:  Am J Nephrol       Date:  2011-11-29       Impact factor: 3.754

2.  ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes.

Authors:  Kunihiro Yamagata; Joichi Usui; Chie Saito; Naoto Yamaguchi; Kouichi Hirayama; Kaori Mase; Masaki Kobayashi; Akio Koyama; Hitoshi Sugiyama; Kosaku Nitta; Takashi Wada; Eri Muso; Yoshihiro Arimura; Hirofumi Makino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2012-02-18       Impact factor: 2.801

3.  A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity.

Authors:  Akio Koyama; Kunihiro Yamagata; Hirofumi Makino; Yoshihiro Arimura; Takashi Wada; Kosaku Nitta; Hiroshi Nihei; Eri Muso; Yoshio Taguma; Hidekazu Shigematsu; Hideto Sakai; Yasuhiko Tomino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-17       Impact factor: 2.801

4.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11
  4 in total
  1 in total

1.  Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis.

Authors:  Aya Imafuku; Naoki Sawa; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Junichi Hoshino; Yoshihumi Ubara; Kenmei Takaichi
Journal:  Clin Rheumatol       Date:  2018-11-27       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.